Navigation Links
Report examines what US can learn from EU chemicals law

BLOOMINGTON, Ind. -- U.S. industry and environmental groups agree that the Toxic Substances Control Act (TSCA) of 1976 needs to be modernized to better protect public health and the environment. However, there is no consensus on what the reform should look like.

A new report from Indiana University supplies a close examination of the European Union's reformed chemicals law REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), which went into effect in 2006.

After reviewing data and interviewing key stakeholders, including manufacturers, importers and REACH experts, researchers from the IU School of Public and Environmental Affairs and the IU European Union Center have released "Regulating Industrial Chemicals: Lessons for U.S. Policy Makers From the European Union's REACH Program."

"As the U.S. Congress considers whether and how to modernize TSCA, much can be learned from the European experience with REACH," said SPEA Dean John D. Graham, a co-author of the report. "Some aspects of REACH are innovative and promising, while others are overly burdensome and complicated."

While the report examines all areas of REACH, the primary focus is on the program's chemical registration process. REACH shifts the burden of proving safety from the government to industry. REACH's key principle -- "no data, no market" -- compels manufacturers of substances, producers of articles and importers to supply regulators a minimum safety-related data set for a large number of existing chemicals.

"One of our most important conclusions is that there needs to be a clear and consistent definition of 'safety' throughout any new chemical regulatory program," said the report's lead author, Adam Abelkop, a doctoral student in SPEA.

Researchers have identified several aspects of the EU program that merit consideration by U.S. policymakers as well as areas that could be refined and modified to be more transparent, simplified and suitable for the U.S. context. Highlights of the report indicate that a REACH-like system in the United States should focus on opportunities to reduce risks to human health and the environment. In addition, new legislation should provide clarification about critical standards, processes and tools while lessening unnecessary burdens on industry by allowing for mutual, cross-Atlantic recognition of registration dossiers.

"This suggestion would ease obligations on companies that do business on both sides of the Atlantic and would lessen the work of the regulators," said REACH consultant Agnes Botos, co-author of the report and a Central European University doctoral student. "That is why it would be worth doing a more detailed analysis about this topic."

According to SPEA professor Lois Wise, co-author of the report and director of the European Union Center and West European Studies at IU, REACH offers an alternative approach to the process of chemical regulation and control providing a greater understanding of how regulatory processes work.

"Our interest is in the extent to which the European experience implementing this complicated and innovative piece of legislation can inform efforts to revise TSCA," she said. "This study, examining the process of REACH implementation, provides useful insight for policymakers."

On March 2, SPEA and the European Union Center will host an invitation-only seminar in Washington, D.C., that includes a panel of international experts who will discuss Europe's early experiences with REACH and issues related to TSCA reform.

Contact: Debbie O'Leary
Indiana University

Related medicine news :

1. Earliest Known Horse Shrank Due to Warming Planet: Report
2. 15% of U.S. Surgeons Report Drinking Problems in Survey
3. New MDC Research Report published
4. U.S. Teen Driving Deaths Up: Report
5. 1 in 10 U.S. Kids Lives With Parent Who Has Abused Alcohol: Report
6. UCLA scientists report link between traumatic brain injury, post-traumatic stress disorder
7. Orthopaedic surgery report provides transparency on patient safety, quality initiatives
8. Fewer Teens Exposed to Tobacco Smoke in Cars: Report
9. Medical debt keeps rising, new report shows
10. More U.S. Babies Born at Home: Report
11. Scientists report first step in strategy for cell replacement therapy in Parkinsons disease
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb ... the leading plastic surgery practices in Florida, is proud to announce that Dr. ... surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational New Drug ... so important to this key industry segment, Regis Technologies has decided to sponsor and ... 4th at 11am EST. , Federal law does not allow new drugs to cross ...
(Date:11/30/2015)... ... November 30, 2015 , ... Healthjump, Inc. ... Inc., a Healthcare IT consulting, development and support company. The purchase will expand ... available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and artists were ... held on November 8th and 9th at the Puerto Rico Convention Center, San Juan ... beauticians and top of the line fashion journalists. The San Juan Beauty Show carries ...
(Date:11/30/2015)... ... 2015 , ... Innovaacom, a leading provider of medical education ... of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, Asia, ... online and face-to-face education for pharmacists who are fast becoming the new “gatekeepers” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... 2015 Elbit Imaging Ltd. (TASE, ... today that it was informed by InSightec Ltd. ("InSightec"), that ... has approved its Exablate Neuro system to treat movement, ... --> Insightec,s Exablate Neuro platform is transforming ... two technologies: Focused Ultrasound, which is used to lesion ...
Breaking Medicine Technology: